Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$7.76M Buy
30,361
+7,851
+35% +$1.95M 0.02% 650
2020
Q3
$5.33M Buy
22,510
+1,622
+8% +$342K 0.02% 713
2020
Q2
$4.06M Buy
20,888
+4,521
+28% +$864K 0.02% 799
2020
Q1
$2.71M Buy
16,367
+3,737
+30% +$683K 0.01% 891
2019
Q4
$2.16M Buy
12,630
+2,276
+22% +$379K 0.01% 1055
2019
Q3
$1.71M Buy
10,354
+2,240
+28% +$315K 0.01% 1123
2019
Q2
$969K Buy
8,114
+1,336
+20% +$137K ﹤0.01% 1416
2019
Q1
$645K Buy
6,778
+1,370
+25% +$117K ﹤0.01% 1599
2018
Q4
$429K Buy
5,408
+450
+9% +$38.1K ﹤0.01% 1770
2018
Q3
$525K Sell
4,958
-18
-0.4% -$1.69K ﹤0.01% 1737
2018
Q2
$426K Buy
4,976
+660
+15% +$59.2K ﹤0.01% 1824
2018
Q1
$374K Buy
4,316
+183
+4% +$14.2K ﹤0.01% 1837
2017
Q4
$285K Buy
+4,133
New +$271K ﹤0.01% 1965

Other funds holding PODD

Aperio Group's PODD Position: Q4 2020 in Review

Aperio Group increased its Insulet (PODD) stake by 35% in Q4 2020, buying an estimated $1.95M and bringing the position to 30,361 shares worth $7.76M. The position accounts for 0.02% of the portfolio, ranked #650.

Aperio Group first reported a position in PODD in Q4 2017 and has held it in 13 quarters since. 465 funds tracked by Wall St. Rank hold PODD as of Q4 2020.

  • Aperio Group held 30,361 shares of Insulet worth $7.76M as of Q4 2020.
  • Aperio Group bought 7,851 Insulet shares in Q4 2020, an estimated $1.95M.
  • Insulet made up 0.02% of Aperio Group's portfolio in Q4 2020, its #650 holding.
  • Aperio Group first reported a position in Insulet in Q4 2017 and has held it in 13 quarters since.
  • 465 funds tracked by Wall St. Rank held Insulet as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.